{
    "GTG 2012 - Initial Mx of Chronic Pelvic Pain.pdf": "1. Chronic Pelvic Pain\n2. Pelvic Pain\n3. Migraine\n4. Low-back pain\n5. Central nervous system\n6. Peripheral nervous system\n7. Tumour necrosis factor alpha (TNF -/H9251)\n8. Chemokines\n9. Visceral hyperalgesia\n10. Neuropathic pain",
    "bjog-2018-jauniaux-placenta-praevia-and-placenta-accreta-diagnos.pdf": "1. Placenta Praevia\n2. Placenta Accreta\n3. Caesarean delivery\n4. Assisted reproductive technology\n5. Maternal smoking\n6. Low-lying placenta\n7. Transvaginal scanning (TVS)\n8. Cervical length measurement\n9. Antenatal corticosteroids\n10. Tocolytics",
    "BJOG - 2018 - Denison - Care of Women with Obesity in Pregnancy.pdf": "1. Obesity in Pregnancy\n2. Prepregnancy care\n3. Antenatal care\n4. Gestational weight gain\n5. Gestational diabetes\n6. Hypertensive complications\n7. Venous thromboembolism\n8. Mental health problems\n9. Chromosomal anomalies\n10. Fetal surveillance",
    "GTG 2008 - Prevention of Entry-Related Laparoscopic Injuries.pdf": "1. Gynaecological laparoscopic injuries\n2. Laparoscopic surgery\n3. Needles, trocars and cannulae\n4. Abdominal wall\n5. Peritoneal cavity\n6. Bowel or vascular injury\n7. Laparoscopic surgeons\n8. Major abdominal reparative surgery\n9. Colostomy\n10. Laparoscopic entry techniques",
    "BJOG - 2017 -  - Management of Breech Presentation.pdf": "Diagnosis: Breech Presentation\n\nInvestigation: \n1. External cephalic version (ECV)\n2. Assessment for risk factors for a poorer outcome in planned vaginal breech birth\n3. Ultrasound to estimate the position of the fetal neck and legs, and the fetal weight \n4. Continuous electronic fetal monitoring \n\nManagement: \n1. Counselling on the risks and benefits of planned vaginal breech delivery versus planned caesarean section\n2. Individualised assessment of the long-term risks of caesarean section based on their individual risk profile and reproductive intentions\n3. Planned caesarean section for breech presentation in spontaneous preterm labour is not recommended\n4. Labour with a preterm breech should be managed as with a term breech\n5. Simulation equipment should be used to rehearse the skills that are needed during vaginal breech birth by all doctors and midwives\n6. Guidance for the case selection and management of vaginal breech birth should be developed in each department by the healthcare professionals who supervise such births\n7. Departments should consider developing a checklist to ensure comprehensive counselling of the woman regarding planned mode of delivery for babies presenting by the breech.",
    "GTG 2016 - Postmenopausal Ovarian Cysts.pdf": "1. Ovarian Cysts\n2. Postmenopausal Women\n3. Serum Cancer Antigen 125 (CA125) Level\n4. Transvaginal Ultrasound Scan\n5. Risk Factors of Ovarian Malignancy\n6. Family History of Ovarian, Bowel or Breast Cancer\n7. Regional Cancer Genetics Service\n8. Irritable Bowel Syndrome\n9. Risk of Malignancy Index (RMI)\n10. Gynaecological Oncology Multidisciplinary Team",
    "RCOG Consent Advice - Laparoscopic Tubal Ectopic.pdf": "1. Laparoscopic Management of Tubal Ectopic Pregnancy\n2. Laparoscopic Salpingectomy\n3. Laparoscopic Salpingotomy\n4. Haemodynamically Unstable\n5. Bowel Injuries\n6. Laparotomy\n7. Blood Transfusion\n8. Oophorectomy\n9. Expectant Management\n10. Methotrexate Therapy",
    "BJOG - 2016 -  - Management of Premenstrual Syndrome.pdf": "1. Premenstrual Syndrome (PMS)\n2. Symptom diary\n3. Gonadotrophin-releasing hormone (GnRH) analogues\n4. Combined oral contraceptives (COCs)\n5. Selective serotonin reuptake inhibitors (SSRIs)\n6. Cognitive behavioural therapy (CBT)\n7. Drospirenone-containing COCs\n8. Percutaneous estradiol\n9. Levonorgestrel-releasing intrauterine system (LNG-IUS)\n10. Danazol",
    "GTG 2011 - APH.pdf": "1. Antepartum haemorrhage (APH)\n2. Placenta praevia\n3. Placental abruption\n4. Perinatal mortality\n5. Maternal mortality\n6. Preterm delivery\n7. Cerebral palsy\n8. Blood transfusion\n9. Obstetric haemorrhage\n10. Maternal collapse",
    "GTG 2016 - Epilepsy in Pregnancy.pdf": "1. Epilepsy\n2. Seizures\n3. Obstetrician\n4. Neurologist\n5. Antiepileptic drugs (AEDs)\n6. Congenital malformations\n7. Eclampsia\n8. Neuropsychiatric conditions\n9. Non-epileptic attack disorder\n10. Folic acid.",
    "Joint RCOG BSGE Guideline - Outpatient Hysteroscopy.pdf": "1. Outpatient Hysteroscopy\n2. Abnormal Uterine Bleeding\n3. Opiate Analgesia\n4. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)\n5. Cervical Preparation\n6. Uterine Trauma\n7. Miniature Hysteroscopes\n8. Flexible Hysteroscopes\n9. Distension Medium\n10. Local Anaesthesia and Cervical Dilatation.",
    "antenatal-care-pdf-66143709695941.pdf": "1. Antenatal care\n2. NICE guideline\n3. Medicines and Healthcare products Regulatory Agency\n4. Yellow Card Scheme\n5. Venous thromboembolism\n6. Gestational diabetes\n7. Pre-eclampsia\n8. Breech presentation\n9. Symptomatic vaginal discharge\n10. Pelvic girdle pain",
    "GTG 2010 - Malaria in Pregnancy - Prevention.pdf": "1. Malaria\n2. Pregnancy\n3. Anopheles mosquito\n4. Red blood cell infection\n5. P. falciparum\n6. P. vivax\n7. P. ovale\n8. P. malariae\n9. P. knowlesi\n10. Chemoprophylaxis",
    "BJOG - 2022 - Stock - Antenatal corticosteroids to reduce neonatal morbidity and mortality.pdf": "1. Antenatal corticosteroids\n2. Neonatal morbidity\n3. Neonatal mortality\n4. Preterm birth\n5. Respiratory distress syndrome\n6. Planned caesarean birth\n7. Hypoglycaemia\n8. Developmental delay\n9. Preterm prelabour rupture of membranes (PPROM)\n10. Intraventricular haemorrhage.",
    "ESHRE PIL - Endometriosis.pdf": "1. Endometriosis\n2. Adenomyosis\n3. Uterine fibroids\n4. Polyps\n5. Laparoscopy\n6. Progestagens\n7. Anti-progestagens\n8. GnRH agonists\n9. Aromatase inhibitors\n10. Infertility",
    "Joint RCOG BASHH Guideline - Genital Herpes in Pregnancy.pdf": "1. Genital Herpes\n2. Pregnancy\n3. Neonatal herpes\n4. Herpes simplex virus type 1 (HSV-1)\n5. Herpes simplex virus type 2 (HSV-2)\n6. Antiviral treatment\n7. Aciclovir\n8. Valaciclovir\n9. Famciclovir\n10. Immunoglobulin G (IgG) antibodies to HSV-1 and HSV-2.",
    "GTG 2015 - Post-hysterectomy Vaginal Vault Prolapse.pdf": "1. Post-Hysterectomy Vaginal Vault Prolapse\n2. Pelvic Organ Prolapse\n3. Urodynamic testing\n4. Pelvic floor multidisciplinary team\n5. Quality of Life measures\n6. McCall culdoplasty\n7. Sacrospinous fixation\n8. Subtotal hysterectomy\n9. Surgical management\n10. Urogynaecologist",
    "BJOG - 2016 -  - Diagnosis and Management of Ectopic Pregnancy.pdf": "1. Ectopic Pregnancy\n2. Tubal Pregnancy\n3. Transvaginal Ultrasound\n4. Serum progesterone level\n5. Serum beta-human chorionic gonadotrophin (b-hCG) level\n6. Cervical Pregnancy\n7. Caesarean Scar Pregnancy\n8. Interstitial Pregnancy\n9. Cornual Pregnancy\n10. Ovarian Pregnancy",
    "GTG 2014 - Endometrial Hyperplasia.pdf": "1. Endometrial Hyperplasia\n2. Royal College of Obstetricians and Gynaecologists (RCOG)\n3. British Society for Gynaecological Endoscopy (BSGE)\n4. Cytological Atypia\n5. Histological Examination\n6. Endometrial Biopsy\n7. Transvaginal Ultrasound\n8. Hysteroscopy\n9. Progestogens\n10. Hormone Replacement Therapy (HRT)",
    "BJOG - 2019 - Chu - Maternal Collapse in Pregnancy and the Puerperium.pdf": "1. Maternal Collapse\n2. Obstetric Modifed Early Warning Score\n3. Anaphylaxis Mast Cell Tryptase Levels\n4. Aortocaval Compression\n5. Resuscitation Council (UK) Guidelines\n6. Perimortem Caesarean Section (PMCS)\n7. Antepartum Haemorrhage\n8. Placental Abruption\n9. Amniotic Fluid Embolism (AFE)\n10. Intravenous Tranexamic Acid",
    "BJOG - 2022 - Shennan - Cervical Cerclage.pdf": "1. Cervical Cerclage\n2. Singleton pregnancies\n3. Preterm births\n4. Second trimester loss\n5. Ultrasound-indicated cerclage\n6. Transvaginal cerclage\n7. Transabdominal cerclage\n8. Cervical insufficiency\n9. Cervical length shortening\n10. Emergency cerclage",
    "NICE Guidance - 2023 - Ectopic.pdf": "1. Ectopic pregnancy\n2. Miscarriage\n3. Early pregnancy complications\n4. Early pregnancy assessment services\n5. Human chorionic gonadotropin (hCG) levels\n6. Recurrent miscarriage\n7. Molar pregnancy\n8. Haemodynamically unstable\n9. Amenorrhoea\n10. Tachycardia.",
    "BMS-GUIDELINE-Management-of-unscheduled-bleeding-HRT-APRIL2024-F.pdf": "1. British Menopause Society\n2. Hormone Replacement Therapy (HRT)\n3. Post Reproductive Health\n4. Endometrial Cancer\n5. Sequential HRT (sHRT)\n6. Continuous Combined HRT (ccHRT)\n7. Risk Factors\n8. Transvaginal Ultrasound (TVS)\n9. Urgent Suspicion of Cancer Pathway (USCP)\n10. Polycystic Ovarian Syndrome (PCOS)",
    "NICE Interventional Guidance - 2007 - Lap Hyst.pdf": "1. Laparoscopic techniques\n2. Hysterectomy\n3. Laparoscopically-assisted vaginal hysterectomy (LAVH)\n4. Laparoscopic hysterectomy (LH)\n5. Laparoscopic supracervical hysterectomy (LSH)\n6. Total laparoscopic hysterectomy (TLH)\n7. Urinary tract injury\n8. Severe bleeding\n9. Advanced laparoscopic skills\n10. Benign Gynaecological Surgery: Laparoscopy.",
    "NICE Guidance - 2010 - Hysterectomy for Endometrial Cancer.pdf": "1. Laparoscopic hysterectomy\n2. Endometrial cancer\n3. Multidisciplinary gynaecological oncology team\n4. Advanced laparoscopic skills\n5. Royal College of Obstetricians and Gynaecologists\n6. Advanced Training Skills Module\n7. International Federation of Gynecology and Obstetrics (FIGO) system\n8. Total hysterectomy with bilateral salpingo-oophorectomy\n9. Radiotherapy, hormone therapy and chemotherapy\n10. Carbon dioxide insufflation.",
    "GTG 2014 - Longterm PCOS Consequences.pdf": "1. Polycystic Ovary Syndrome (PCOS)\n2. Rotterdam consensus criteria\n3. Gestational diabetes\n4. Body mass index (BMI)\n5. Oral glucose tolerance test\n6. Impaired fasting glucose\n7. Sleep apnoea\n8. Cardiovascular disease (CVD)\n9. Endometrial hyperplasia\n10. Insulin-sensitising agents",
    "BJOG - 2017 -  - Management of Inherited Bleeding Disorders in Pregnancy.pdf": "1. Inherited Bleeding Disorders\n2. Haemophilia\n3. Clotting factor VIII\n4. Clotting factor IX\n5. Genetic counselling\n6. Prenatal diagnosis\n7. Factor VIII/IX levels\n8. Tranexamic acid\n9. Desmopressin (DDAVP)\n10. Recombinant factor VIII/IX",
    "ESHRE Guideline - 2022 - Endometriosis.pdf": "1. ESHRE Endometriosis Guideline Development Group\n2. European Society of Human Reproduction and Embryology\n3. Clinical practice guideline\n4. Healthcare professionals\n5. Endometriosis\n6. Clinical recommendations\n7. Clinical judgment\n8. Healthcare delivery\n9. Patient population\n10. Clinical decisions",
    "BJOG - 2016 -  - Management of Monochorionic Twin Pregnancy.pdf": "1. Monochorionic Twin Pregnancy\n2. Prenatal Ultrasound Chorionicity Allocation\n3. Twin-to-Twin Transfusion Syndrome (TTTS)\n4. Twin Anaemia-Polycythaemia Sequence (TAPS)\n5. Selective Growth Restriction (sGR)\n6. Fetoscopic Laser Ablation\n7. Quintero System\n8. Umbilical Artery Doppler Velocities\n9. Fetal Magnetic Resonance Imaging\n10. Monochorionic Monoamniotic (MCMA) Pregnancies",
    "Joint RCOG and BSGE Guideline- Laparoscopy in Pregnancy.pdf": "1. Laparoscopic management\n2. Non-obstetric, abdominal conditions\n3. Pregnancy\n4. Gynaecological Endoscopy\n5. Acute appendicitis\n6. Acute gall bladder disease\n7. Symptomatic benign adnexal tumours\n8. Obstetricians and gynaecologists\n9. General surgeons and anaesthetists\n10. Laparoscopists",
    "GTG 2015 - FGM.pdf": "1. Female Genital Mutilation (FGM)\n2. Female Genital Mutilation Act 2003\n3. Prohibition of Female Genital Mutilation (Scotland) Act 2005\n4. Female genital cosmetic surgery (FGCS)\n5. Re-infibulation\n6. Health and Social Care Information Centre (HSCIC) FGM Enhanced Dataset\n7. FGM safeguarding risk assessment tool\n8. Obstetricians and Gynaecologists\n9. De-infibulation\n10. Clitoral reconstruction",
    "BJOG - 2022 - Girling - Intrahepatic cholestasis of pregnancy.pdf": "1. Intrahepatic cholestasis of pregnancy (ICP)\n2. Itching in skin of normal appearance\n3. Raised peak random total bile acid concentration of 19 micromol/L or more\n4. Atypical clinical symptoms\n5. Relevant comorbidities\n6. Abnormal liver function tests\n7. Serum bile acid concentration is 100 micromol/L or more\n8. Risk of stillbirth\n9. Fetal ultrasound and/or cardiotocography (CTG)\n10. Obstetric Cholestasis",
    "NICE Guidance - 2022 - Preterm Labour and Birth.pdf": "1. Preterm labour\n2. NICE guideline\n3. Prophylactic vaginal progesterone\n4. Prophylactic cervical cerclage\n5. Transvaginal ultrasound\n6. Preterm prelabour rupture of membranes (P-PROM)\n7. Antenatal prophylactic antibiotics\n8. Maternal corticosteroids\n9. Magnesium sulfate for neuroprotection\n10. Neonatal care.",
    "NICE Quality Standard - 2018 - Endometriosis.pdf": "1. Endometriosis\n2. Quality standard\n3. Hormonal treatment\n4. Gynaecology service\n5. Abdominal examination\n6. Pelvic examination\n7. Chronic pelvic pain\n8. Deep endometriosis\n9. Specialist endometriosis service\n10. Patient experience.",
    "Joint RCOG BSGE Guideline - Suspected Ovarian Masses in Premenopausal Women.pdf": "1. Ovarian Masses\n2. Premenopausal Women\n3. Benign Gynaecological Service\n4. Gynaecological Oncological Service\n5. Borderline Ovarian Tumours\n6. Laparoscopic Management\n7. Ovarian Malignancies\n8. Ovarian Cysts\n9. Alphafetoprotein (\u03b1-FP)\n10. Human Chorionic Gonadotrophin (hCG)",
    "GTG 2011 - Pregnancy and Breast Cancer.pdf": "1. Breast Cancer\n2. Obstetricians\n3. Gynaecologists\n4. Fertility Specialists\n5. Midwives\n6. Oncologists\n7. Breast Care Nurses\n8. Mastectomy\n9. Lactation\n10. Infertility",
    "BHIVA-Pregnancy-guidelines-2020-3rd-interim-update.pdf.pdf": "1. HIV in pregnancy\n2. Postpartum management\n3. Antiretroviral therapy (ART)\n4. Vertical transmission of HIV\n5. Co-infection with other agents\n6. HIV-2\n7. Psychosocial care\n8. Breastfeeding\n9. Infant post-exposure prophylaxis (PEP)\n10. Hepatitis virus co-infections",
    "BJOG - 2017 -  - Prevention of Early\u2010onset Neonatal Group B Streptococcal Disease.pdf": "1. Early-onset Neonatal Group B Streptococcal Disease\n2. Group B streptococcal (GBS) colonisation\n3. Antenatal screening\n4. Intrapartum antibiotic prophylaxis (IAP)\n5. GBS bacteriuria\n6. GBS urinary tract infection\n7. Maternal GBS carriage\n8. Preterm labour\n9. Polymerase chain reaction\n10. Early-onset neonatal infection",
    "BJOG - 2021 - Navaratnam - Amniocentesis and chorionic villus sampling.pdf": "1. Amniocentesis\n2. Chorionic villus sampling (CVS)\n3. Aneuploidy screening\n4. Cell free DNA testing\n5. Transabdominal CVS\n6. Transvaginal CVS\n7. Midtrimester amniocentesis\n8. Intra-amniotic infection\n9. Prophylactic anti D\n10. Non-invasive prenatal testing (NIPT)",
    "GTG 2016 - OHSS.pdf": "1. Ovarian Hyperstimulation Syndrome (OHSS)\n2. Fertility Treatment\n3. Human Fertilisation and Embryology Authority (HFEA)\n4. Ascitic Fluid\n5. Low Molecular Weight Heparin (LMWH)\n6. Gonadotrophin-Releasing Hormone Antagonists\n7. Dopamine Agonists\n8. Haematocrit\n9. Intravascular Volume Depletion\n10. Pre-Eclampsia.",
    "BJOG - 2017 -  - External Cephalic Version and Reducing the Incidence of Term Breech Presentation.pdf": "Diagnosis:\n- Term Breech Presentation\n- Noncephalic birth\n\nInvestigation:\n- External Cephalic Version (ECV)\n- ECV success prediction models\n- Use of tocolysis with betamimetics\n- Use of regional analgesia or neuraxial blockade\n- Testing for fetomaternal haemorrhage\n\nManagement:\n- ECV should be offered at term from 37+0 weeks of gestation\n- In nulliparous women, ECV may be offered from 36+0 weeks of gestation\n- ECV should only be performed by a trained practitioner or by a trainee working under direct supervision\n- ECV should be performed where facilities for monitoring and surgical delivery are available\n- Following ECV, Electronic Fetal Monitoring (EFM) is recommended\n- Women undergoing ECV who are D negative should be offered anti-D\n- Consideration of the use of moxibustion for breech presentation at 33 \u201335 weeks of gestation, under the guidance of a trained practitioner\n- No evidence that postural management alone promotes spontaneous version to cephalic presentation.",
    "ca1_diagnostichysteroscopy19012011.pdf": "1. Diagnostic hysteroscopy\n2. General anaesthesia\n3. Endometrial biopsy\n4. Removal of polyp\n5. Insertion of levonorgestrel-releasing intrauterine system\n6. Treatment of fibroids\n7. Division of adhesions\n8. Obesity\n9. Pre-existing medical conditions\n10. Laparoscopy or laparotomy in the event of perforation.",
    "BASHH Guideline 2019 - PID.pdf": "1. Pelvic Inflammatory Disease\n2. European Medicines Agency\n3. Fluoroquinolone antibiotics\n4. M genitalium\n5. Gonorrhoea\n6. Ceftriaxone\n7. UK Teratology Information Service\n8. Neisseria gonorrhoeae\n9. Chlamydia trachomatis\n10. Mycoplasma genitalium",
    "BJOG - 2020 -  Management of Gestational Trophoblastic Disease.pdf": "1. Gestational Trophoblastic Disease\n2. Molar pregnancies\n3. Hyperemesis\n4. Uterine enlargement\n5. Hyperthyroidism\n6. Pre-eclampsia\n7. Theca lutein cysts\n8. Metastatic disease\n9. Human chorionic gonadotrophin (hCG)\n10. Trophoblastic neoplasia",
    "BJOG - 2016 -  - Management of Bladder Pain Syndrome.pdf": "1. Bladder Pain Syndrome (BPS)\n2. Urinary Tract Infection (UTI)\n3. Urological Malignancy\n4. Urinary Ureaplasma\n5. Chlamydia\n6. Overactive Bladder\n7. Stress Urinary Incontinence\n8. Voiding Dysfunction\n9. Hunner Lesions\n10. Neuromodulation",
    "GTG 2010 - Malaria in Pregnancy - Treatment.pdf": "1. Malaria in pregnancy\n2. Green-top Guideline No. 54b\n3. Plasmodium falciparum\n4. Parasitic infection\n5. Prophylaxis\n6. Cytoadherence\n7. Sequestration\n8. Fetal growth restriction\n9. Low birth weight\n10. Antimalarial treatment",
    "NICE Guideline - 2021 - IOL.pdf": "1. Inducing labour\n2. NICE guideline\n3. Labour complications\n4. Patient preferences\n5. Adverse events\n6. Medicines and Healthcare products Regulatory Agency\n7. Yellow Card Scheme\n8. Healthcare professionals\n9. Commissioners and providers\n10. Patient experience in adult NHS services.",
    "RCOG Consent Advice - Diagnostic Laparoscopy.pdf": "1. Diagnostic Laparoscopy\n2. Consent Form 1\n3. RCOG Clinical Governance Advice\n4. RCOG Green-top Guideline No. 49\n5. Hydrotubation\n6. Tissue Biopsy\n7. Ovarian Cyst Aspiration\n8. Treatment of Endometriosis\n9. Division of Adhesions\n10. Laparotomy",
    "BJOG - 2016 -  - Prevention and Management of Postpartum Haemorrhage.pdf": "1. Postpartum haemorrhage (PPH)\n2. Antenatal anaemia\n3. Uterine massage\n4. Prophylactic uterotonics\n5. Oxytocin\n6. Ergometrine\n7. Intravenous tranexamic acid\n8. Clinical shock\n9. Intravenous access\n10. Fibrinogen replacement",
    "GTG 2015 - Blood transfusion in Obstetrics.pdf": "1. Blood Transfusion\n2. Obstetrics\n3. Haemoglobin\n4. Anaemia in pregnancy\n5. Oral iron\n6. Parenteral iron\n7. Recombinant human erythropoietin (rHuEPO)\n8. Intrapartum anaemia\n9. Postpartum anaemia\n10. Obstetric haemorrhage",
    "GTG 2015 - Chickenpox in Pregnancy.pdf": "1. Varicella prevention\n2. Varicella-zoster virus immunoglobulin G (VZV IgG)\n3. Postpartum immunisation\n4. Varicella-zoster immunoglobulin (VZIG)\n5. Fetal varicella syndrome (FVS)\n6. Varicella DNA by polymerase chain reaction (PCR)\n7. Aciclovir\n8. Neonatal varicella\n9. Fetal medicine specialist\n10. Varicella vaccination",
    "BJOG - 2019 - Thomson - Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24 0 Weeks of.pdf": "1. Preterm Prelabour Rupture of Membranes (PPROM)\n2. Sterile speculum examination\n3. Insulin-like growth factor-binding protein 1 (IGFBP-1)\n4. Placental alpha microglobulin-1 (PAMG-1)\n5. Erythromycin\n6. Corticosteroids\n7. Chorioamnionitis\n8. C-reactive protein\n9. White cell count\n10. Magnesium sulfate",
    "GTG 2011 - Suspected Ovarian Masses in Premenopausal Women.pdf": "1. Ovarian Masses\n2. Premenopausal Women\n3. Green-top Guideline No. 62\n4. RCOG/BSGE Joint Guideline\n5. Gynaecological Oncological Service\n6. Borderline Ovarian Tumours\n7. Laparoscopic Management\n8. Ovarian Cysts\n9. Endometriosis\n10. Ovarian Cancer",
    "BJOG - 2020 - Murphy - Assisted Vaginal Birth.pdf": "1. Assisted Vaginal Birth\n2. Epidural Analgesia\n3. Latent Phase of Labour\n4. Active Phase of Labour\n5. Rotational and Midpelvic Assisted Vaginal Birth\n6. Fetal Malposition\n7. Vacuum Extraction\n8. Subgaleal Haemorrhage\n9. Scalp Trauma\n10. Obstetric Anal Sphincter Injury (OASI)",
    "GTG 2015 - Birth After Previous CS.pdf": "1. Caesarean Birth\n2. Antenatal care schedule\n3. Vaginal birth after previous caesarean delivery (VBAC)\n4. Elective repeat caesarean section (ERCS)\n5. Uterine rupture\n6. Classical caesarean scar\n7. Placenta praevia\n8. Intrapartum management\n9. Epidural analgesia\n10. Electronic fetal monitoring",
    "GTG 2010 - Late IUD and Stillbirth.pdf": "1. Late Intrauterine Fetal Death (IUFD)\n2. Stillbirth\n3. Singleton fetus\n4. Obstetricians\n5. Midwives\n6. Fetocide\n7. Fetus papyraceous\n8. Perinatal Mortality Surveillance Report (CEMACH)\n9. Small-for-gestational-age fetuses\n10. Confidential Enquiries into Stillbirths and Deaths in Infancy (CESDI)"
}